1.2 ML plerixafor 20 MG/ML Injection [Mozobil]

RxCUI
828703
RxNorm name
1.2 ML plerixafor 20 MG/ML Injection [Mozobil]
Display name
1.2 ML plerixafor 20 MG/ML Injection [Mozobil]
Full name
1.2 ML plerixafor 20 MG/ML Injection [Mozobil]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MozobilPLERIXAFORSanofi-Aventis U.S. LLC0ed08d2b-5051-46b2-aa37-1d6275bf90032025-09-22Warnings, Adverse reactionsExact identifier
rxcui: 828703

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
0ed08d2b-5051-46b2-aa37-1d6275bf90031.2 ML plerixafor 20 MG/ML Injection [Mozobil]SBD24These highlights do not include all the information needed to use MOZOBIL safely and effectively. See full prescribing information for MOZOBIL. MOZOBIL ® (plerixafor) injection, for subcutaneous use Initial U.S. Approval: 200820250922
0ed08d2b-5051-46b2-aa37-1d6275bf9003Mozobil 24 MG per 1.2 ML InjectionSY24These highlights do not include all the information needed to use MOZOBIL safely and effectively. See full prescribing information for MOZOBIL. MOZOBIL ® (plerixafor) injection, for subcutaneous use Initial U.S. Approval: 200820250922
0ed08d2b-5051-46b2-aa37-1d6275bf9003Mozobil 24 MG in 1.2 ML InjectionPSN24These highlights do not include all the information needed to use MOZOBIL safely and effectively. See full prescribing information for MOZOBIL. MOZOBIL ® (plerixafor) injection, for subcutaneous use Initial U.S. Approval: 200820250922